AMG-167

• Description :

  AMG-167 is an anti-cancer monoclonal antibody targeting sclerostin. AMG-167 can be studied in research for osteoporosis[1][2].

• UNSPSC :

  12352203

• Target :

  Wnt

• Related Pathways :

  Stem Cell/Wnt

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• References & Citations :

  [1]MacNabb, C., et al., (2016) . Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges. Journal of osteoporosis, 2016, 6217286.|[2]Dede, A. D., et al., (2017) . Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments. Expert opinion on investigational drugs, 26 (10), 1137–1144.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  No Development Reported

• CAS Number :

  [1798349-30-0]